Streams
Eight Scientific Tracks
Abstracts are invited on original research, programme evaluations, surveillance findings, implementation research, innovations, case studies and policy analyses across any of the eight tracks below. Each track carries its own code, which forms part of your abstract reference. Tap a card to see its focus areas.
- Epidemic Preparedness, Clinical Readiness & One Health
- The Silent Pandemic of Antimicrobial Resistance
- Digital Health & AI in Infectious Disease Diagnosis
- Policy, Financing & Equity in Infectious Disease Response
Viral Haemorrhagic Fevers
Lassa, Ebola and emerging threats — surveillance, clinical management, outbreak response and vaccine research.
- Epidemiology and outbreak dynamics of VHF in Nigeria and West Africa
- Clinical management protocols, novel therapeutics and supportive care
- Genomic surveillance and infectious disease sequencing
- Vaccine development pipeline, with Lassa fever in focus
- Community engagement and infection prevention in endemic areas
HIV/AIDS & Tuberculosis
Co-infections, treatment outcomes, drug resistance, prevention programmes and the path to epidemic control.
- Progress towards the UNAIDS 95-95-95 targets in Nigeria
- Long-acting antiretroviral therapy — evidence and rollout
- TB-HIV co-infection: optimising dual management
- Drug-resistant TB — surveillance, diagnosis and outcomes
- Integration of HIV services into primary healthcare
Malaria
Towards elimination in Nigeria — vector control, case management, resistance monitoring and community strategies.
- Malaria vaccine rollout — implementation and experience in Nigeria
- Insecticide resistance and vector control innovations
- Artemisinin partial resistance: implications for Nigeria
- Malaria in pregnancy — new evidence and updated guidelines
- Digital health tools for malaria surveillance
Antimicrobial Stewardship
The silent pandemic — stewardship programmes in Nigerian hospitals, prescribing practice and resistance surveillance.
- Status of AMR in Nigeria — the AMR 2.0 National Action Plan
- Hospital-acquired infections and infection prevention & control
- Antimicrobial resistance and stewardship in practice
- NAFDAC regulation on counterfeit medicines and rational antibiotic use
- Combating AMR through the One Health approach
Neglected Tropical Diseases
Mass drug administration, elimination mapping, morbidity management and reaching underserved communities.
- Mass drug administration — coverage, impact and challenges
- Lymphatic filariasis, onchocerciasis and schistosomiasis elimination
- Snakebite envenomation as a neglected public health emergency
- Mpox — epidemiology, clinical features and vaccine readiness
- Community-directed treatment for sustainable NTD control
Epidemic Preparedness & One Health
Clinical readiness, cross-sector collaboration and the human–animal–environment interface in outbreak prevention.
- IHR compliance and Nigeria's Joint External Evaluation scores
- NCDC early warning and response system strengthening
- Climate change and the re-emergence of infectious diseases
- Collaboration across human, animal and environmental health
- Preparedness and response — innovations, challenges and future directions
Diagnostics & Digital Health
Laboratory medicine, point-of-care testing, artificial intelligence and data systems for faster detection.
- Point-of-care diagnostics in resource-limited settings
- Genomics, metagenomics and next-generation sequencing in outbreaks
- Artificial intelligence in diagnosis and surveillance
- National laboratory network strengthening, peripheral to reference
- Telemedicine and e-health platforms for ID consultation
Health Systems, Financing & Policy
Health financing, workforce, governance and the policy decisions that determine how Nigeria responds.
- Impact of global health financing constraints on Nigeria's response
- Vaccine manufacturing and self-reliance — Nigeria's roadmap
- Health insurance and universal coverage for infectious disease care
- Workforce development — training ID specialists for Nigeria's needs
- Advocacy for increased government investment in ID research